Scalp Cooling in MBC

PHASE2RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 7, 2021

Primary Completion Date

June 1, 2026

Study Completion Date

June 1, 2028

Conditions
Metastatic Breast CancerChemotherapy-induced Alopecia
Interventions
DEVICE

Paxman Scalp Cooling System

Cap attached to coolant lines connected to a refrigeration unit placed on scalp

DRUG

Eribulin

Intravenous Infusion

DRUG

Sacituzumab govitecan

Intravenous Infusion

DRUG

Trastuzumab deruxtecan

Intravenous Infusion

Trial Locations (2)

02115

RECRUITING

Brigham and Women's Hospital, Boston

RECRUITING

Dana Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

Paxman Coolers Limited

UNKNOWN

collaborator

AstraZeneca

INDUSTRY

collaborator

Eisai Inc.

INDUSTRY

collaborator

Daiichi Sankyo

INDUSTRY

collaborator

Gilead Sciences

INDUSTRY

lead

Dana-Farber Cancer Institute

OTHER